SCHEMBL7960358

SCHEMBL7960358

Cc1cc(CC2CCCC=C2c2nc(-c3ccccc3)c(-c3ccccc3)o2)cc(C(=O)O)c1

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.79
PTGIR P43119 5/20 0.79
PTGER1 P34995 1/20 0.79
PTGER3 P43115 1/20 0.60
RXRA P19793 5/20 0.40
RXRB P28702 5/20 0.40
RXRG P48443 3/20 0.40
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
NR4A2 P43354 6/20 0.36
FABP4 P15090 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
NR4A1 P22736 1/20 0.34
NR4A3 Q92570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961753 0.91 PTGER4 (0.69) PTGER4PTGIRPTGER1PTGER3RXRA
SCHEMBL1626140 0.88 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL4576000 0.88 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7960055 0.88 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7959550 0.88 PTGIR (0.66) PTGER4PTGIRPTGER1PTGER3RXRA
SCHEMBL7957721 0.87 PTGER4 (0.81) PTGER4PTGIRPTGER1PTGER3RXRA
SCHEMBL7960451 0.87 PTGER4 (0.81) PTGER4PTGIRPTGER1PTGER3RXRA
SCHEMBL7959445 0.87 PTGIR (0.86) PTGER4PTGIRPTGER1PTGER3RXRA
SCHEMBL7478122 0.86 PTGER4 (0.71) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7960399 0.85 PTGIR (0.94) PTGER4PTGIRPTGER1PTGER3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed